Trials / Completed
CompletedNCT01561469
Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin
Multicenter, Retrospective, Observational Study to Evaluate Clinical and Economic Outcomes of Patients With MRSA Hospital-Acquired Pneumonia Treated With Linezolid Or Vancomycin
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 188 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to review the local management of patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia treated with vancomycin or linezolid with the goal to define if any difference exists among these antimicrobials in regard to clinical and economic outcomes.
Detailed description
Non-randomized, retrospective, observational study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Linezolid | Patients with documented MRSA hospital-acquired or ventilator-associated pneumonia treated with linezolid according to routine medical care. |
| DRUG | Vancomycin | Patients with documented MRSA hospital-acquired or ventilator-associated pneumonia treated with vancomycin according to routine medical care. |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-03-23
- Last updated
- 2014-07-10
- Results posted
- 2014-07-10
Source: ClinicalTrials.gov record NCT01561469. Inclusion in this directory is not an endorsement.